Dianthus Therapeutics stock shot higher Monday after the company said it would advance its experimental CIDP treatment.

Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

The 12-16-week open-label study evaluated Ruxoprubart as monotherapy in treatment-naïve PNH patients. Key findings include: CLEVELAND, March 09, 2026 (GLOBE NEWSWIRE) -- NovelMed Therapeutics Inc., a ...

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...

Spherix Global Insights today announces the release of its latest Market Dynamix(TM): Paroxysmal Nocturnal Hemoglobinuria (PNH) (US) 2026 study, revealing a sizable population of patients eligible for ...

New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...

Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...

GAINESVILLE, FL - March 09, 2026 - PRESSADVANTAGE - Awaken Chiropractic operates as a chiropractic practice in ...

Today’s gold prices see the precious metal move up from yesterday. Here are today’s gold futures prices and a quick snapshot of where gold was yesterday, as well as overall trends: Gold futures open ...

Maple Leaf Foods suggested it is committed to the plant-based meat category in the wake of the spin-off of its pork ...

Here we'll try to look at and discuss the best players whom the Browns must target during 2026 NFL free agency.

Every morning, people fasten their watch, slip on a bracelet and head out the door without thinking much about what they might encounter along the way. The air they breathe, the dust on their hands ...